254 related articles for article (PubMed ID: 15812353)
1. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
[TBL] [Abstract][Full Text] [Related]
2. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
[TBL] [Abstract][Full Text] [Related]
3. The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells.
Mikhalap SV; Shlapatska LM; Yurchenko OV; Yurchenko MY; Berdova GG; Nichols KE; Clark EA; Sidorenko SP
Blood; 2004 Dec; 104(13):4063-70. PubMed ID: 15315965
[TBL] [Abstract][Full Text] [Related]
4. CD150-mediated Akt signalling pathway in normal and malignant B cells.
Yurchenko M; Shlapatska LM; Romanets OL; Ganshevskiy D; Kashuba E; Zamoshnikova A; Ushenin YV; Snopok BA; Sidorenko SP
Exp Oncol; 2011 Mar; 33(1):9-18. PubMed ID: 21423089
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells.
Morra M; Lu J; Poy F; Martin M; Sayos J; Calpe S; Gullo C; Howie D; Rietdijk S; Thompson A; Coyle AJ; Denny C; Yaffe MB; Engel P; Eck MJ; Terhorst C
EMBO J; 2001 Nov; 20(21):5840-52. PubMed ID: 11689425
[TBL] [Abstract][Full Text] [Related]
6. CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.
Mikhalap SV; Shlapatska LM; Berdova AG; Law CL; Clark EA; Sidorenko SP
J Immunol; 1999 May; 162(10):5719-27. PubMed ID: 10229804
[TBL] [Abstract][Full Text] [Related]
7. CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells.
Yurchenko MY; Kovalevska LM; Shlapatska LM; Berdova GG; Clark EA; Sidorenko SP
Immunol Cell Biol; 2010 Jul; 88(5):565-74. PubMed ID: 20231852
[TBL] [Abstract][Full Text] [Related]
8. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines.
Kis LL; Nagy N; Klein G; Klein E
Int J Cancer; 2003 May; 104(5):658-61. PubMed ID: 12594824
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).
Eissmann P; Beauchamp L; Wooters J; Tilton JC; Long EO; Watzl C
Blood; 2005 Jun; 105(12):4722-9. PubMed ID: 15713798
[TBL] [Abstract][Full Text] [Related]
10. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation.
Malbec O; Fong DC; Turner M; Tybulewicz VL; Cambier JC; Fridman WH; Daƫron M
J Immunol; 1998 Feb; 160(4):1647-58. PubMed ID: 9469421
[TBL] [Abstract][Full Text] [Related]
11. Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation.
Howie D; Simarro M; Sayos J; Guirado M; Sancho J; Terhorst C
Blood; 2002 Feb; 99(3):957-65. PubMed ID: 11806999
[TBL] [Abstract][Full Text] [Related]
12. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.
Gordiienko IM; Shlapatska LM; Kovalevska LM; Sidorenko SP
Exp Oncol; 2016 Jun; 38(2):101-7. PubMed ID: 27356578
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
15. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.
Wain CM; Westwick J; Ward SG
Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794
[TBL] [Abstract][Full Text] [Related]
16. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
[TBL] [Abstract][Full Text] [Related]
17. SAP couples Fyn to SLAM immune receptors.
Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
[TBL] [Abstract][Full Text] [Related]
18. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling.
Ono M; Okada H; Bolland S; Yanagi S; Kurosaki T; Ravetch JV
Cell; 1997 Jul; 90(2):293-301. PubMed ID: 9244303
[TBL] [Abstract][Full Text] [Related]
19. The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity.
Baran CP; Tridandapani S; Helgason CD; Humphries RK; Krystal G; Marsh CB
J Biol Chem; 2003 Oct; 278(40):38628-36. PubMed ID: 12882960
[TBL] [Abstract][Full Text] [Related]
20. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]